XBP1 and inflammatory bowel disease: ERS becomes an essential mediator of macrophage decomposition [29], and the IRE1/XBP1 signaling pathway in ERS can mediate the inflammatory response of macrophages [30], suggesting that modulating ERS's impact of ERS on macrophages can provide a novel potential target for IBD therapy.